|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Urinary Tract Infection | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Communicable Diseases | |||||
| Infection | |||||
| Urinary Tract Infections | |||||
| 3 | More general conditions related to this trial | ||||
| Urologic Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| LACTIN-V | |||||
| placebo | |||||
| 5 | Sponsors listed in this trial | ||||
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | |||||
| Osel, Inc. | |||||